Published in Hospital Law Weekly, March 25th, 2010
"We report an extremely long duration of chemotherapy with ixabepilone and capecitabine (42 cycles) in a patient with triple-negative metastatic breast cancer previously treated with anthracyclines and taxanes. Partial remission was achieved, and acceptable toxicity was observed," wrote E. Vrdoljak and colleagues, University Hospital.
The researchers concluded: "This report adds to the pool of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly